Articles

• Open Access

  Apheresis therapies for NMOSD attacksA retrospective study of 207 therapeutic interventions

  Ingo Kleiter, Anna Gahlen, Nadja Borisow, Katrin Fischer, Klaus-Dieter Wernecke, Kerstin Hellwig, Florence Pache, Klemens Ruprecht, Joachim Havla, Tania Kümpfel, Orhan Aktas, Hans-Peter Hartung, Marius Ringelstein, Christian Geis, Christoph Kleinschnitz, Achim Berthele, Bernhard Hemmer, Klemens Angstwurm, Jan-Patrick Stellmann, Simon Schuster, Martin Stangel, Florian Lauda, Hayrettin Tumani, Christoph Mayer, Markus Krumbholz, Lena Zeltner, Ulf Ziemann, Ralf Linker, Matthias Schwab, Martin Marziniak, Florian Then Bergh, Ulrich Hofstadt-van Oy, Oliver Neuhaus, Uwe K. Zettl, Jürgen Faiss, Brigitte Wildemann, Friedemann Paul, Sven Jarius, Corinna Trebst, on behalf of NEMOS (Neuromyelitis Optica Study Group)

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Population-based study of “no evident disease activity” in MS

  Natalie E. Parks, Sean J. Pittock, Jay Mandrekar, Orhun H. Kantarci, Claudia F. Lucchinetti, Brian G. Weinshenker, B. Mark Keegan, W. Oliver Tobin, Jan-Mendelt Tillema, Michel Toledano, Eoin P. Flanagan

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD

  Amal P.R. Samaraweera, Yasser Falah, Alain Pitiot, Robert A. Dineen, Paul S. Morgan, Nikos Evangelou

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders

  Andrea Marcinnò, Fabiana Marnetto, Paola Valentino, Serena Martire, Alessia Balbo, Aurora Drago, Maria Leto, Marco Capobianco, Giancarlo Panzica, Antonio Bertolotto

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes

  Giulia Longoni, Robert A. Brown, Berengere Aubert-Broche, Stephanie A. Grover, Helen M. Branson, Dumitru Fetco, Amit Bar-Or, Ruth Ann Marrie, Robert W. Motl, D. Louis Collins, Sridar Narayanan, Douglas L. Arnold, Brenda Banwell, E. Ann Yeh

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins

  Madalina E. Carter-Timofte, Anders F. Hansen, Maibritt Mardahl, Sébastien Fribourg, Franck Rapaport, Shen-Ying Zhang, Jean-Laurent Casanova, Søren R. Paludan, Mette Christiansen, Carsten S. Larsen, Trine H. Mogensen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Varied antibody reactivities and clinical relevance in anti-GQ1b antibody–related diseases

  Keisuke Yoshikawa, Motoi Kuwahara, Miyuki Morikawa, Yuta Fukumoto, Masaki Yamana, Yuko Yamagishi, Susumu Kusunoki

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Disruption of neurite morphology parallels MS progression

  Barbara Spanò, Giovanni Giulietti, Valerio Pisani, Manuela Morreale, Elisa Tuzzi, Ugo Nocentini, Ada Francia, Carlo Caltagirone, Marco Bozzali, Mara Cercignani

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions

  Riley Bove, Priya Garcha, Carolyn J. Bevan, Elizabeth Crabtree-Hartman, Ari J. Green, Jeffrey M. Gelfand

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Gender differences in prednisone adverse effectsSurvey result from the MG registry

  Ikjae Lee, Henry J. Kaminski, Tarrant McPherson, Michelle Feese, Gary Cutter

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Dimethyl fumarate as a first- vs second-line therapy in MSFocus on B cells

  Elsebeth Staun-Ram, Eiman Najjar, Anat Volkowich, Ariel Miller

  • Abstract
  • Full Text
  • Full Text (PDF)